Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease
Apr 15, 2018
In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
SUBSCRIBE: Print / eNewsletter
In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.
In view of the potential for durable responses with immunotherapy, it will be important to identify the most effective and least toxic regimens for individual patients.